The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
The presence of persistent high‐risk hpv genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months
Abstract
To evaluate the clinical significance of HPV genotyping for the prediction of progressive cervical intraepithelial neoplasia (CIN) in women with cytomorphologically abnormal smears, a prospective, blind, non‐intervention study was performed. A total of 342 patients screened with cytomorphologically abnormal cervical smears were monitored every 3–4 months by cervical cytology, colposcopy and HPV testing using PCR. Women with progressive CIN disease were defined as patients developing lesions with a colposcopic impression of CIN III over more than 2 quadrants or resulting in a cytological smear equivalent to Pap 5. These patients were subsequently treated according to standard procedures. If any doubt arose about the true status of the patients (n = 75) these patients were censored and biop‐sied. The mean follow‐up time was 16.5 months (range 3–36 months). Nineteen women showed progressive CIN disease and all appeared to be continuously HPV‐positive from the start of the study. At biopsy, all these patients were histologically classified as CIN III. Seventeen of these women were positive for high‐risk HPV types. Two cases were classified as still unidentified HPV. No progression was seen in the absence of HPV DNA or in the presence of low‐risk HPV types. In life‐table analysis the cumulative rate of progressive, histologically verified CIN disease was 17% after 36 months. Further analyses showed that other risk factors such as age, sexarche, number of sexual partners or smoking hardly influenced the effect of HPV on progression. The results show that the continuous presence of high‐risk HPV types in women with cytomorphologically abnormal smears is a strong marker for progressive CIN disease. ©1995 Wiley Liss. Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schiffman, M. H., Bauer, H. M., Hoover, R. N., Glass, A. G., Cadell, D. M., Rush, B. B., Scott, D. R., Sherman, M. E., Kurman, R. J., Wacholder, S., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.12.958 · Cited by 1,210
Bauer, H. M. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460040048027 · Cited by 952
Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D., & Kiviat, N. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271804 · Cited by 943
Human papillomaviruses in the pathogenesis of anogenital cancer
zur Hausen, H. (1991) · Virology · doi:10.1016/0042-6822(91)90816-t · Cited by 847
LORINCZ, A. T., REID, R., JENSON, B. A., GREENBERG, M. D., LANCASTER, W., & KURMAN, R. J. (1992) · Obstetrics & Gynecology · doi:10.1097/00006250-199203000-00002 · Cited by 775
Mills, J. M., & Stier, E. A. (2021) · 50 Studies Every Obstetrician-Gynecologist Should Know · doi:10.1093/med/9780190947088.003.0031 · Cited by 756
The Papanicolaou Test for Cervical Cancer Detection: A Triumph and a Tragedy
Koss, L. G. (1989) · JAMA · doi:10.1001/jama.1989.03420050087046 · Cited by 645
Munoz, N., Bosch, F. X., de Sanjose, S., Tafur, L., Izarzugaza, I., Gili, M., Viladiu, P., Navarro, C., Martos, C., Ascunce, N., et al. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520513 · Cited by 568
A follow-up study of patients with cervical dysplasia
Richart, R. M., & Barron, B. A. (1969) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(69)90268-3 · Cited by 391
Melkert, P. W. J., van den Brule, A. J. C., Risse, E. K. J., van Diest, P. J., Meijer, C. J. L. M., Walboomers, J. M. M., Helmerhorst, T., Hopman, E., Bleker, O. P., & Schipper, M. E. I. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530609 · Cited by 281
Self-citationDiagnostic Molecular Pathology. A Practical Approach
Underwood, J. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.5.487-d · Cited by 242
Phylogenetic Classification of Human Papillomaviruses: Correlation With Clinical Manifestations
Van Ranst, M., Kaplan, J. B., & Burk, R. D. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-10-2653 · Cited by 214
Human papillomavirus type 16 DNA in cervical smears as predictor of high-grade cervical cancer
Cuzick, J., Terry, G., Ho, L., Hollingworth, T., & Anderson, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)91532-d · Cited by 163
Schiffman, M. H., Bauer, H. M., Lorincz, A. T., Manos, M. M., Byrne, J. C., Glass, A. G., Cadell, D. M., & Howley, P. M. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.3.573-577.1991 · Cited by 158
Chan, S. Y., Bernard, H., Ong, C. K., Chan, S. P., Hofmann, B., & Delius, H. (1992) · Journal of Virology · doi:10.1128/jvi.66.10.5714-5725.1992 · Cited by 128
Husman, A. D. R., Walboomers, J. M. M., Meijer, C. J. L. M., Risse, E. K. J., Schipper, M. E. I., Helmerhorst, T. J. M., Bleker, O. P., Delius, H., van den Brule, A. J. C., & Snijders, P. J. F. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560607 · Cited by 103
Self-citationMeijer, C. J. L. M., van den Brule, A. J. C., Snijders, P. J. F., Helmerhorst, T. J. M., Kenemans, P., & Walboomers, J. M. M. (1992) · PubMed · Cited by 95
Self-citationPrognostic Factors in Cervical Human Papillomavirus Infections
Kataja, V. V., SYRJANEN, S., MÄNTYJÄRVI, R. A., Yliskoski, M. H., Saarikoski, S., & Syrjänen, K. J. (1992) · Sexually Transmitted Diseases · doi:10.1097/00007435-199205000-00009 · Cited by 53
Cited by
The causal relation between human papillomavirus and cervical cancer
Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.4.244 · Cited by 3,538
Self-citationNobbenhuis, M. A., Walboomers, J. M., Helmerhorst, T. J., Rozendaal, L., Remmink, A. J., Risse, E. K., van der Linden, H. C., Voorhorst, F. J., Kenemans, P., & Meijer, C. J. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12490-x · Cited by 685
Self-citationGravitt, P. E., Peyton, C. L., Apple, R. J., & Wheeler, C. M. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.10.3020-3027.1998 · Cited by 646
Immune responses to human papillomavirus
Stanley, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.09.002 · Cited by 586
Jacobs, M. V., Snijders, P. J., van den Brule, A. J., Helmerhorst, T. J., Meijer, C. J., & Walboomers, J. M. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.3.791-795.1997 · Cited by 568
Self-citation
Metadata
- Authors
- Remmink, A. J., Walboomers, J. M. M., Helmerhorst, T. J. M., Voorhorst, F. J., Rozendaal, L., Risse, E. K. J., Meijer, C. J. L. M., & Kenemans, P.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1995-05-04
- Volume
- 61
- Issue
- 3
- Pages
- 306-311
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2009334997
- Cited by
- 368
- References
- 18
- FWCI
- 15.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.